427 related articles for article (PubMed ID: 21180290)
21. Hypercalcemia induced by parathyroid hormone-related peptide after treatment of carcinoma.
Gover A; Kumar PD; Brown LA; Ravakhah K
South Med J; 2002 Feb; 95(2):258-60. PubMed ID: 11846257
[TBL] [Abstract][Full Text] [Related]
22. Malignant hypercalcemia in vulvar cancer.
Bilenchi R; Poggiali S; Pisani C; Santopietro R; Miracco C; Vatti R; Lucani B; Andreassi A; Gonnelli S
Minerva Ginecol; 2005 Oct; 57(5):569-74. PubMed ID: 16205603
[TBL] [Abstract][Full Text] [Related]
23. [Paraneoplastic endocrine syndromes: clinical picture and laboratory diagnostics].
Igaz P
Magy Onkol; 2023 Jun; 67(2):102-105. PubMed ID: 37314070
[TBL] [Abstract][Full Text] [Related]
24. Paraendocrine syndromes.
Pierce ST
Curr Opin Oncol; 1993 Jul; 5(4):639-45. PubMed ID: 8364080
[TBL] [Abstract][Full Text] [Related]
25. Hypercalcemia-leukocytosis syndrome associated with lung cancer.
Hiraki A; Ueoka H; Takata I; Gemba K; Bessho A; Segawa Y; Kiura K; Eguchi K; Yoneda T; Tanimoto M; Harada M
Lung Cancer; 2004 Mar; 43(3):301-7. PubMed ID: 15165088
[TBL] [Abstract][Full Text] [Related]
26. [Paraneoplastic syndromes: a review].
Berardi R; Grilli G; Romagnoli E; Saladino T; Freddari F; Tamburrano T; Galizia E; Carbonari G; Mariani C; Braconi C; Pierantoni C; Battelli N; Scartozzi M; Cascinu S
Clin Ter; 2005; 156(6):281-8. PubMed ID: 16463565
[TBL] [Abstract][Full Text] [Related]
27. Paraneoplastic neurological syndrome in systemic cancer.
Oğul E; Bakar M; Tokat E; Bora I; Zarifoğlu M; Turan F; Karli N
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):271-4. PubMed ID: 9216820
[TBL] [Abstract][Full Text] [Related]
28. [Paraneoplastic endocrine syndromes in O.R.L. (ectopic secretion of polypeptide hormones)].
Pinel J; Trotoux J
J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1980 Feb; 29(2):97-107. PubMed ID: 6445411
[No Abstract] [Full Text] [Related]
29. Endocrine manifestations of cancer and its treatment.
Shalet SM
Practitioner; 1981 Jun; 225(1356):829-36. PubMed ID: 7301756
[No Abstract] [Full Text] [Related]
30. [Paraneoplastic endocrine syndromes].
Ariyoshi Y
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2023-30. PubMed ID: 3013095
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic syndromes in cancer: Case 3. Parathyroid hormone-related hypercalcemia in cholangiocarcinoma.
Yen Y; Chu PG; Feng W
J Clin Oncol; 2004 Jun; 22(11):2244-5. PubMed ID: 15169815
[No Abstract] [Full Text] [Related]
32. Oncology Grand Rounds. Small cell lung cancer and paraneoplastic syndromes.
Hainsworth JD; Greco FA
J Tenn Med Assoc; 1980 Feb; 73(2):111-4. PubMed ID: 6245310
[No Abstract] [Full Text] [Related]
33. Hypercalcemic complication in patients with oral squamous cell carcinoma.
Iwase M; Takemi T; Manabe M; Nagumo M
Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
[TBL] [Abstract][Full Text] [Related]
34. [Simultaneous production of parathyroid hormone-related protein (PTHrP) and granulocyte colony-stimulating factor (G-CSF) in lung cancer patients with hypercalcemia and leukocytosis].
Sakamoto A; Katakami H; Mukae H; Taniguchi H; Maki H; Ashitani J; Ihi T; Dohtsu Y; Matsukura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jan; 33(1):34-8. PubMed ID: 7535368
[TBL] [Abstract][Full Text] [Related]
35. Endocrine/metabolic syndromes of cancer.
Odell WD
Semin Oncol; 1997 Jun; 24(3):299-317. PubMed ID: 9208886
[TBL] [Abstract][Full Text] [Related]
36. [Management of paraneoplastic syndrome in lung cancer].
Inoue K; Nakanishi Y
Nihon Rinsho; 2002 May; 60 Suppl 5():536-9. PubMed ID: 12101730
[No Abstract] [Full Text] [Related]
37. Paraneoplastic syndromes in patients with oral cancer.
Toro C; Rinaldo A; Silver CE; Politi M; Ferlito A
Oral Oncol; 2010 Jan; 46(1):14-8. PubMed ID: 19932048
[TBL] [Abstract][Full Text] [Related]
38. Non-small-cell lung cancer with multiple paraneoplastic syndromes.
Monsieur I; Meysman M; Noppen M; de Greve J; Delhove O; Velckeniers B; Jacobvitz D; Vincken W
Eur Respir J; 1995 Jul; 8(7):1231-4. PubMed ID: 7589410
[TBL] [Abstract][Full Text] [Related]
39. Syndrome of inappropriate antidiuretic hormone secretion due to recurrent oral cancer.
Danielides V; Milionis HJ; Karavasilis V; Briasoulis E; Elisaf MS
B-ENT; 2005; 1(3):151-3. PubMed ID: 16255500
[TBL] [Abstract][Full Text] [Related]
40. Exacerbation of paraneoplastic syndrome of inappropriate antidiuretic hormone by parenteral nutrition in a patient affected by a large-cell neuroendocrine pancreatic cancer.
Giovanis P; Garna A; Marcante M; Mascanzoni A; Giusto M
J Pain Symptom Manage; 2006 Nov; 32(5):395-6. PubMed ID: 17085261
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
